Mineral ·Insufficient evidence ·Reviewed May 2026
Low-dose lithium supplement for neuroprotection and mood support.
The bottom line
Evidence rating insufficient. Most-documented uses: mood support, neuroprotection, brain health. 14 sources indexed (1986–2024), with 12 interaction records on file.
Core mechanism
Inhibits GSK-3beta, promotes BDNF expression, and supports autophagy. At low doses, provides neuroprotective benefits without prescription lithium side effects.6,7
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Lithium Orotate.
Assumes 5-20 mg elemental lithium/day. Vendor basis: NOW/iHerb, Vitacost, Life Extension, and Amazon marketplace; low-dose capsules remain inexpensive. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Foods and drinking water contain only trace lithium, and lithium orotate is a supplemental salt that should not be matched through diet.
What to test, the optimal window inside the conventional range, and how long a response takes.
Lithium orotate at supplemental doses raises serum lithium minimally. Doses above 20 mg elemental warrant monitoring.2,3
Draw 12 hours after last dose for consistency. Even microdoses can affect thyroid and kidney function over years; check TSH and creatinine annually with long-term use.
Lithium and iodine both affect the thyroid gland, and using them together can increase the likelihood of hypothyroidism or goiter through compounded suppression of thyroid hormone output.
Recommendation: Use caution when combining. Monitor thyroid function (TSH and free T4) and consult a clinician before pairing lithium orotate with iodine, especially with existing thyroid disease.
Inositol counteracts part of lithium's proposed mechanism by replenishing the inositol pool that lithium depletes, which may blunt lithium's mood-stabilizing effect when the two are used together.
Recommendation: Be cautious combining the two if lithium is being used for mood stabilization. Discuss with a clinician, since high-dose inositol may oppose lithium's intended action.
Combining psilocybin with lithium has been associated in case reports and online experience reports with seizures and severe adverse neurological reactions, making this one of the most dangerous documented psychedelic combinations.
Recommendation: Do not combine. If you take any lithium-containing product, do not use psilocybin and seek medical advice.
Taking psyllium husk concurrently with lithium orotate can blunt lithium absorption and lower its effective dose. This is supported by a documented case in which a patient on lithium showed falling lithium levels after starting ispaghula (psyllium) husk, with levels rising again within days of stopping the fiber at an unchanged lithium dose. The interaction is one of timing and physical binding rather than a metabolic effect, so it is largely avoidable by spacing the two apart.
Recommendation: Separate psyllium husk and lithium orotate by at least 2 to 3 hours (take lithium first, then fiber later, or vice versa). Keep daily fiber intake and timing consistent so lithium exposure stays stable rather than fluctuating. If you use prescription lithium, do not change your psyllium routine without telling your prescriber, since dose adjustments may have been made around your fiber habits and serum lithium monitoring is warranted.
Enalapril reduces sodium reabsorption and lowers glomerular filtration, which causes the kidney to retain lithium and pushes serum lithium levels up. In prescription-lithium patients started on enalapril, lithium concentrations have risen by roughly a third within weeks. Lithium Orotate doses are much smaller, but the same handling principle applies and the margin between therapeutic and toxic lithium is narrow; older adults, dehydrated patients, and those on diuretics or NSAIDs are most at risk.
Recommendation: Avoid Lithium Orotate while taking enalapril. If you must use it, keep the dose low, stay well hydrated, and ask your prescriber to check a serum lithium level after a week or two. Hold lithium during any vomiting, diarrhea, or fever illness.
Ramipril reduces sodium reabsorption and lowers glomerular filtration, which causes the kidney to retain lithium. Case reports with ACE inhibitors describe lithium toxicity developing within 3 to 5 weeks of starting the medication, sometimes with serum lithium concentrations rising more than 30%. Lithium Orotate doses are smaller but use the same renal pathway and the margin to neurotoxicity is narrow, particularly in older adults or anyone who becomes dehydrated.
Recommendation: Avoid Lithium Orotate while taking ramipril. If you must combine them, keep the dose low, stay well hydrated, and ask your prescriber to check a serum lithium level after 1-2 weeks. Hold the supplement during any vomiting, diarrhea, or fever.
Benazepril is an ACE inhibitor that reduces sodium reabsorption and lowers glomerular filtration. This causes the kidney to retain lithium and raises serum lithium concentrations. Case series of patients on prescription lithium have shown rises of about 36% in steady-state lithium levels after starting an ACE inhibitor. Lithium Orotate doses are smaller, but the same renal handling applies and the margin to toxicity is narrow.
Recommendation: Avoid Lithium Orotate while taking benazepril. If used together, keep the dose low, stay well hydrated, and ask your prescriber to check serum lithium after 1-2 weeks. Hold the supplement during any vomiting, diarrhea, or fever.
Valsartan reduces sodium reabsorption through AT1 receptor blockade and lowers glomerular filtration, which causes the kidney to retain lithium. Multiple case reports describe prescription-lithium patients developing toxicity within weeks of starting or increasing valsartan, sometimes at previously safe doses. Lithium Orotate doses are smaller, but the same renal handling applies and the margin to neurotoxicity is narrow.
Recommendation: Avoid Lithium Orotate while taking valsartan. If you must combine them, keep the dose low, stay well hydrated, and ask your prescriber to check a serum lithium level after 1-2 weeks. Hold the supplement during any vomiting, diarrhea, or fever.
Losartan blocks the AT1 receptor and reduces sodium reabsorption, which causes the kidney to retain lithium. A published case described a previously stable prescription-lithium patient developing tremor, confusion, and elevated lithium levels within weeks of starting losartan 50 mg. Lithium Orotate doses are smaller but use the same renal pathway and the therapeutic window is narrow.
Recommendation: Avoid Lithium Orotate while taking losartan. If you must combine them, keep the dose low, stay well hydrated, and ask your prescriber to check serum lithium after 1-2 weeks. Hold the supplement during any vomiting, diarrhea, or fever.
Irbesartan blocks the AT1 receptor, reduces sodium reabsorption, and increases lithium retention by the kidney. Multiple published cases with ARBs describe lithium toxicity developing weeks after starting therapy, sometimes at previously well-tolerated lithium doses. Lithium Orotate doses are smaller but use the same renal pathway and the therapeutic window is narrow.
Recommendation: Avoid Lithium Orotate while taking irbesartan. If you must combine them, keep the dose low, stay well hydrated, and ask your prescriber to check serum lithium after 1-2 weeks. Hold the supplement during vomiting, diarrhea, or fever.
Olmesartan blocks the AT1 receptor, reduces sodium reabsorption, and increases lithium retention by the kidney. Multiple case reports with ARBs describe lithium toxicity developing weeks after starting therapy, sometimes at previously safe lithium doses. Lithium Orotate doses are smaller but use the same renal pathway and the therapeutic window is narrow.
Recommendation: Avoid Lithium Orotate while taking olmesartan. If you must combine them, keep the dose low, stay well hydrated, and ask your prescriber to check serum lithium after 1-2 weeks. Hold the supplement during vomiting, diarrhea, or fever.
The valsartan component blocks AT1 receptors, reduces sodium reabsorption, and increases lithium retention by the kidney. A published case described an 81-year-old on chronic lithium developing progressive tremor, ataxia, and cognitive decline after starting sacubitril/valsartan. Lithium Orotate doses are smaller but use the same renal pathway, and the therapeutic window is narrow.
Recommendation: Avoid Lithium Orotate while taking sacubitril/valsartan. If you must combine them, keep the dose low, stay well hydrated, and ask your cardiologist to check serum lithium after 1-2 weeks. Hold the supplement during vomiting, diarrhea, or fever.
Numbered references. Citations throughout the page link here.
Sharif S, Chen B, Brewster P et al.. Rationale and Design of Assessing the Effectiveness of Short-Term Low-Dose Lithium Therapy in Averting Cardiac Surgery-Associated Acute Kidney Injury: A Randomized, Double Blinded, Placebo Controlled Pilot Trial. Frontiers in medicine. 2021
Schrauzer GN, de Vroey E. Effects of nutritional lithium supplementation on mood. A placebo-controlled study with former drug users. Biological trace element research. 1994
Allain P, Le Bouil A, Turcant A et al.. [Pharmacokinetics of low-dose lithium in healthy volunteers]. Therapie. 1994
Lithium's ability to counteract cognitive decline appears to be exerted at subtherapeutic doses; may reduce inflammation and induce neuroprotection at doses several folds lower than clinical use.
Low-dose lithium reduces neurofibrillary tangles and amyloid beta production, reduces neuroinflammation, promotes BDNF expression, and provides neuroprotection at subtherapeutic doses.
Lithium inhibits GSK-3 directly and indirectly by enhancing serine phosphorylation; BDNF induction required for lithium's neuroprotection to occur.
Lithium has neuroprotective and neurotrophic actions; promotes expression of BDNF; counteracts cognitive decline at subtherapeutic doses with fewer side effects than standard psychiatric doses.
Sartori HE. Lithium orotate in the treatment of alcoholism and related conditions. Alcohol (Fayetteville, N.Y.). 1986
Major Danish study found long-term lithium exposure in drinking water may be associated with lower incidence of dementia in a nonlinear (U-shaped) relationship.
Inverse correlation between drinking water lithium concentrations and all-cause mortality in 18 Japanese municipalities (1,206,174 individuals); low-dose lithium extended C. elegans lifespan.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack